Non-invasive PD-L1 quantification using [(18)F]DK222-PET imaging in cancer immunotherapy

BACKGROUND: Combination therapies that aim to improve the clinical efficacy to immune checkpoint inhibitors have led to the need for non-invasive and early pharmacodynamic biomarkers. Positron emission tomography (PET) is a promising non-invasive approach to monitoring target dynamics, and programme...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Akhilesh, Gupta, Kuldeep, Kumar, Dhiraj, Lofland, Gabriela, Sharma, Ajay Kumar, Solnes, Lilja B, Rowe, Steven P, Forde, Patrick M, Pomper, Martin G, Gabrielson, Edward W, Nimmagadda, Sridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551964/
https://www.ncbi.nlm.nih.gov/pubmed/37793856
http://dx.doi.org/10.1136/jitc-2023-007535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551964/
https://www.ncbi.nlm.nih.gov/pubmed/37793856
http://dx.doi.org/10.1136/jitc-2023-007535

Ejemplares similares